In continuation of the work he started with France Biobank and Luxembourg Bone and Tissue Bank in Europe in 2010, he made great contributions to the "regulation on human tissues and cells" studies with the Ministry of Health in Turkey in order to strengthen the supervision of the Allograft market and increase the quality, and the regulation was approved on 27 October 2010. It was published in the official gazette.It became the first company in Turkey to receive official sales permission in 2012.He was the distributor of France Biobank, Luxembourg Bone and Tissue Bank, EMCM Tissue Bank and American Bacterin Tissue Banks in Turkey.In 2014, T.R. Social Security Institution carried out reimbursement (SUT) studies.In 2015, the Dutch Tissue Bank in Turkey transferred the eCOO Supercritical Allograft production technology from EMCM.It has created Turkey's first and only tissue and bone bank that produces human-derived tissue with the superior eCOO® Supercritical Co2 technology, with the most up-to-date and reliable technology in the field of processing human bones and tissues.It organizes business development programs with Tissue Banks in Europe in the Human Sourced Tissue sector.It continues to contribute to relevant institutions in Turkey and its R&D studies in the field of tissue and technology developmentFor high quality and safety in Tissue Banking, it has trained and professionalized its special production team in the field of bioengineering and molecular genetic sciences.Orbone wants to bring the quality of Allograft tissues to all surgeons in the world.